Magnetic Resonance Imaging (MRI)-Compatible Syringe Pump Market Global Report 2026

The magnetic resonance imaging (MRI)-compatible syringe pump market size has grown strongly in recent years. It will grow from $0.32 billion in 2025 to $0.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing adoption of MRI diagnostic procedures, rising demand for accurate contrast agent administration, growing need for patient safety during imaging procedures, expansion of advanced diagnostic imaging facilities, increasing utilization of infusion systems in critical care applications.

The magnetic resonance imaging (MRI)-compatible syringe pump market size is expected to see strong growth in the next few years. It will grow to $0.46 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for advanced MRI guided procedures, rising adoption of programmable infusion technologies, growing integration of smart monitoring capabilities, expanding healthcare infrastructure investments, increasing focus on precision medication delivery. Major trends in the forecast period include increasing adoption of mri compatible infusion technologies, growing development of programmable syringe pump systems, rising demand for safe contrast agent delivery solutions, expansion of non-magnetic medical device designs, increasing preference for continuous infusion during imaging procedures.

The increasing global prevalence of complex chronic diseases is expected to drive the growth of the magnetic resonance imaging-compatible syringe pump market in the coming years. Complex chronic diseases refer to the presence of one or more long-term health conditions that are severe, progressive, or interconnected and require continuous, coordinated, and multidisciplinary healthcare management. The increasing prevalence of complex chronic diseases worldwide is fueled by the aging population, as older individuals have a higher risk of developing multiple chronic health conditions that require ongoing and integrated medical care. The growing burden of complex chronic diseases increases the requirement for continuous medication infusion during magnetic resonance imaging (MRI) procedures, thereby boosting the demand for magnetic resonance imaging-compatible syringe pumps that enable safe and accurate drug delivery while supporting effective diagnosis and uninterrupted treatment for patients with multiple chronic conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, 76.4% (194 million) of US adults had at least one chronic condition in 2023, while 51.4% (130 million) were affected by multiple chronic conditions. Therefore, the increasing global prevalence of complex chronic diseases is contributing to the expansion of the magnetic resonance imaging-compatible syringe pump market.

The growing number of magnetic resonance imaging procedures is expected to drive the growth of the magnetic resonance imaging-compatible syringe pump market in the forecast period. Magnetic resonance imaging procedures refer to non-invasive diagnostic imaging tests that utilize strong magnetic fields and radio waves to generate detailed images of internal organs, tissues, and anatomical structures. The increasing number of magnetic resonance imaging procedures is supported by the rising demand for accurate and non-invasive diagnostic imaging solutions, as MRI enables detailed visualization of soft tissues and organs without the use of ionizing radiation. The rising adoption of magnetic resonance imaging (MRI) procedures is increasing the demand for magnetic resonance imaging-compatible syringe pumps to facilitate the safe and continuous administration of contrast agents and medications during imaging procedures. For instance, in December 2025, according to the National Institutes of Health, a US-based government agency, CT imaging activity increased by 60% and MRI activity increased by 31%, indicating continued growth in diagnostic imaging procedures over time. Therefore, the growing number of magnetic resonance imaging procedures is driving the growth of the magnetic resonance imaging-compatible syringe pump market.

Key companies operating in the magnetic resonance imaging (MRI)-compatible syringe pump market are concentrating on developing MRI-compatible infusion solutions, including integrated syringe pump stations, to enhance medication safety, ensure uninterrupted drug delivery, and improve workflow efficiency during magnetic resonance imaging procedures. These systems provide MRI-safe operation, continuous infusion capabilities, remote monitoring, and compatibility with high-strength magnetic field environments, enabling clinicians to administer essential medications without interrupting diagnostic imaging or compromising patient safety. For example, in August 2023, Mindray, a China-based medical device company, launched the BeneFusion MRI Station, an MRI-compatible infusion solution designed to support safe and continuous medication delivery throughout MRI examinations. The system integrates MRI-compatible syringe and infusion pumps with centralized monitoring capabilities, allowing healthcare professionals to maintain accurate infusion therapy while minimizing workflow disruptions in MRI suites. It provides a dedicated MRI-compatible infusion platform. Mindray enables hospitals to improve medication safety, enhance clinical efficiency, and support uninterrupted patient care during MRI procedures.

Major companies operating in the magnetic resonance imaging (mri)-compatible syringe pump market report are B. Braun Melsungen AG, Fresenius Kabi AG, Becton Dickinson and Company, Bracco Imaging S.p.A., Guerbet SA, ulrich medical USA Inc., IRadimed Corporation, ICU Medical Inc., Nemoto Kyorindo Co. Ltd., Shenzhen Antmed Co. Ltd., Chemyx Inc., Harvard Apparatus, MEDTRON AG, Apollo RT Co. Ltd.

North America was the dominant region in the magnetic resonance imaging (MRI)-compatible syringe pump market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the magnetic resonance imaging (MRI)-compatible syringe pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the magnetic resonance imaging (MRI)-compatible syringe pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.